KIT and renal cell carcinoma: Baghdadi et al. [26] stated that both ChRCC and RO have CD117 (+) protein biomarkers, unavailable in other RCC tumors; hence, it is difficult to distinguish between the two tumors, as their morphological characteristics overlap.